STATERA BIOPHARMA
Statera BioPharma is a biotechnology research agency that provides biotechnology research services. The company was founded in 2014 and is headquartered in Fort Collins, Colorado, United States.
STATERA BIOPHARMA
Industry:
Biopharma Biotechnology Health Care Medical
Founded:
2014-01-01
Address:
Fort Collins, Colorado, United States
Country:
United States
Website Url:
http://www.staterabiopharma.com
Total Employee:
11+
Status:
Active
Contact:
888-613-8802
Total Funding:
26.14 M USD
Technology used in webpage:
Apple Mobile Web Clips Icon Amazon HSTS ReCAPTCHA Person Schema Facebook Sharer Gravatar Profiles Apple Mobile Web App Capable ReCAPTCHA V2 Amazon Virginia Region
Similar Organizations
Acasti Pharma
Acasti Pharma is an emerging biopharmaceutical company.
Cabaletta Bio
Cabaletta Bio has adapted clinically-validated and FDA-approved CAR T cell technology to target B cell-mediated autoimmune diseases.
Cytrellis Biosystems
Cytrellis is a medical technology company that develops aesthetic devices.
NephroDI Therapeutics
NephroDI Therapeutics is a biopharmaceutical company that focuses on the concentration disorders of the kidney.
Halo Labs
Halo Labs is a biotechnology company that specializes in analytical instrumentation and biopharma.
Pioneering Medicines
Pioneering Medicines is a biotechnology research agency providing biotechnology to life sciences services.
Prolocor
Prolocor is a biotechnology company that develops diagnostic tests for cardiovascular diseases.
Trevarx Biomedical
Trevarx Biomedical is a biomedical startup that develops new radiopharmaceuticals.
Current Employees Featured
Official Site Inspections
http://www.staterabiopharma.com Semrush global rank: 6.34 M Semrush visits lastest month: 1.05 K
- Host name: box5938.bluehost.com
- IP address: 96.125.174.28
- Location: Houston United States
- Latitude: 29.8284
- Longitude: -95.4696
- Metro Code: 618
- Timezone: America/Chicago
- Postal: 77092
More informations about "Statera BioPharma"
About Statera Biopharma - Statera Biopharma: …
Statera Biopharma, Inc.’s foundation is based on restoring immune health through the leveraging of complex pleiotropic beneficial effects.See details»
Statera BioPharma - Wikipedia
Statera BioPharma, Inc. is an American clinical-stage biopharmaceutical company with a focus on novel immunotherapies. In 2021, Cleveland BioLabs merged with Cytocom, Inc, a clinical-stage biopharmaceutical company developing novel immunotherapies targeting autoimmune, inflammatory, infectious diseases, and cancers. The new compa…See details»
Statera Biopharma Company Profile | Management and Employees …
Headquartered in Fort Collins, Colorado, Statera Biopharma is a biopharmaceutical company creating next-generation immune therapies that focus on immune restoration and …See details»
October 2021 Corporate Presentation - Statera Biopharma
Immunology research organization to define additional mechanism of actions (MOAs) of platform HISTORY. October 2021 4 Statera Biopharma intends to become the leader in developing and …See details»
Statera BioPharma, Inc. - LinkedIn
Statera Biopharma’s foundation is based on restoring immune health through the leveraging of complex, pleiotropic beneficial effects.See details»
Statera Biopharma, Inc. (STAB) Company Profile & Overview
Nov 22, 2024 Statera BioPharma, Inc., a clinical-stage biopharmaceutical company, develops novel immunotherapies targeting autoimmune, neutropenia/anemia, emerging viruses, and …See details»
Statera BioPharma - Crunchbase Company Profile & Funding
Statera BioPharma is a biotechnology research agency that provides biotechnology research services. The company was founded in 2014 and is headquartered in Fort Collins, Colorado, …See details»
Statera Biopharma - Craft
Jun 21, 2024 Statera Biopharma (formerly known as Cytocom) is a pre-clinical and clinical biopharmaceutical company that develops product candidates for treating diseases involving …See details»
Statera Biopharma - Overview, News & Similar companies
Jan 30, 2023 Statera Biopharma Signs Letter of Intent for Merger with Worksite Labs FORT COLLINS, Colo., March 15, 2023 (GLOBE NEWSWIRE) -- Statera Biopharma, Inc. …See details»
Statera Biopharma - VentureRadar
Statera Biopharma, Inc. (formerly Cytocom, Inc.) is a clinical-stage biopharmaceutical company developing novel immunotherapies targeting autoimmune, neutropenia/anemia, emerging …See details»
staterabiopharma.com Reviews: Is this site a scam or legit?
While some are self-explanatory concerning staterabiopharma.com, let's dive deeper into the remaining ones. Proximity to Potentially Harmful Websites. This metric gauges the connection, …See details»
Subsidiaries & Partners - Statera Biopharma: Restoring Immune …
Incuron’s clinical lead curaxin CBL0137, demonstrated significant anti-cancer activity in a number of preclinical tumor models, including colon, pancreatic, prostate and breast adenocarcinomas, …See details»
Company Statera Biopharma, Inc. Nasdaq - MarketScreener.com
Feb 23, 2022 Statera BioPharma, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing immunotherapies autoimmune, neutropenia/anemia, …See details»
Statera Biopharma - PitchBook
Statera Biopharma General Information Description. Statera BioPharma Inc is a pre-clinical and clinical biopharmaceutical company developing multiple product candidates to address unmet …See details»
Our Science - Statera Biopharma: Restoring Immune Health
STAT-600 Oncology and Hematology: The STAT-600 program looks to leverage the data obtained from numerous trials and studies conducted with TLR5 variants over the years, …See details»
Statera BioPharma, Inc. Provides Update on Integration of ImQuest
Sep 1, 2021 ImQuest BioSciences, Inc., a contract research organization (CRO), now operates as a separate, wholly owned, revenue-generating subsidiary of Statera. ... To learn more …See details»
Biostax Corp. and Statera Biopharma, Inc. reach mutually beneficial ...
Apr 20, 2023 The settlement between Statera Biopharma, Inc. and Biostax Corp. includes an amended royalty-bearing license agreement and a joint petition to dismiss the involuntary …See details»
News - Statera Biopharma: Restoring Immune Health
Oct 6, 2021 FORT COLLINS, Colo., Sept. 2, 2021 /PRNewswire/ -- Statera BioPharma, Inc. (Nasdaq: STAB), a leading biopharmaceutical company creating next-generation immune …See details»
For Patients - Statera Biopharma: Restoring Immune Health
COVID-19 This is an exploratory, randomized, placebo controlled, multi-center study to assess the pharmacokinetics and biomarkers of STAT-201 as a potential treatment to slow or halt the …See details»